Warning: The NCBI web site requires JavaScript to function. more...
HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function.
Sossdorf M, Marx S, Schaarschmidt B, Otto GP, Claus RA, Reinhart K, Hartog CS, Lösche W.
Crit Care. 2009;13(6):R208. Epub 2009 Dec 22.
Related citations
Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis.
Niemi TT, Kuitunen AH.
Acta Anaesthesiol Scand. 2005 Mar;49(3):373-8.
In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT.
Konrad CJ, Markl TJ, Schuepfer GK, Schmeck J, Gerber HR.
Anesth Analg. 2000 Feb;90(2):274-9.
[Effects of plasma substitutes on hemostasis].
Blanloeil Y, Trossaërt M, Rigal JC, Rozec B.
Ann Fr Anesth Reanim. 2002 Oct;21(8):648-67. French.
Hydroxyethyl starch interferes with human blood ex vivo coagulation, platelet function and sedimentation.
Liu FC, Liao CH, Chang YW, Liou JT, Day YJ.
Acta Anaesthesiol Taiwan. 2009 Jun;47(2):71-8.
Effects on coagulation of balanced (130/0.42) and non-balanced (130/0.4) hydroxyethyl starch or gelatin compared with balanced Ringer's solution: an in vitro study using two different viscoelastic coagulation tests ROTEMTM and SONOCLOTTM.
Casutt M, Kristoffy A, Schuepfer G, Spahn DR, Konrad C.
Br J Anaesth. 2010 Sep;105(3):273-81. Epub 2010 Jul 21.
[Thrombelastographic coagulation analysis following in vitro and in vivo haemodilution with hydroxyethyl starch (HES)].
Asskali F, Lehmann G, Förster H.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2002 May;37(5):258-66. German.
In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation.
Ruttmann TG, James MF, Aronson I.
Br J Anaesth. 1998 May;80(5):612-6.
Hydroxyethyl starch impairs in vitro coagulation.
Acta Anaesthesiol Scand. 1998 Oct;42(9):1104-9.
Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight.
Entholzner EK, Mielke LL, Calatzis AN, Feyh J, Hipp R, Hargasser SR.
Acta Anaesthesiol Scand. 2000 Oct;44(9):1116-21.
A new plasma-adapted hydroxyethyl starch preparation: in vitro coagulation studies.
Boldt J, Mengistu A.
J Cardiothorac Vasc Anesth. 2010 Jun;24(3):394-8. Epub 2009 Dec 11. Retraction in: J Cardiothorac Vasc Anesth. 2011 Aug;25(4):755-7.
Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%.
De Lorenzo C, Calatzis A, Welsch U, Heindl B.
Anesth Analg. 2006 Apr;102(4):1194-200.
Effects of PentaLyte and Voluven hemodilution on plasma coagulation kinetics in the rabbit: role of thrombin-fibrinogen and factor XIII-fibrin polymer interactions.
Nielsen VG.
Acta Anaesthesiol Scand. 2005 Oct;49(9):1263-71.
Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography.
Jamnicki M, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR.
Anesth Analg. 1998 Nov;87(5):989-93.
In vitro effects of gelatin solutions on platelet function: a comparison with hydroxyethyl starch solutions.
Thaler U, Deusch E, Kozek-Langenecker SA.
Anaesthesia. 2005 Jun;60(6):554-9.
Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
Acta Anaesthesiol Scand. 2005 Sep;49(8):1163-71.
Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation.
Egli GA, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR.
Br J Anaesth. 1997 Jun;78(6):684-9.
The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery.
Haisch G, Boldt J, Krebs C, Kumle B, Suttner S, Schulz A.
Anesth Analg. 2001 Mar;92(3):565-71.
A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch.
Strauss RG, Pennell BJ, Stump DC.
Transfusion. 2002 Jan;42(1):27-36.
Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate.
Fenger-Eriksen C, Anker-Møller E, Heslop J, Ingerslev J, Sørensen B.
Br J Anaesth. 2005 Mar;94(3):324-9. Epub 2004 Dec 17.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on